Calcium diphosphate is a calcium phosphate.
Definition
Calcium diphosphate is a calcium phosphate. It contains a diphosphate(4-).
Source: PubChem
US FDA substance register · UNII X69NU20D19 · registered name CALCIUM PYROPHOSPHATE · single chemical substance
Cosmetic roles
Safety & regulatory references
Not classified under Korea’s toxic-substance GHS list · existing chemical substance
Other restriction: ban substances that deplete the ozone layer
Source: EU CosIng ingredient list
Reviewed by CIR: Safety Assessment of Phosphoric Acid and Its Salts as Used in Cosmetics
More data — names, identifiers, properties, test records, literature
Official labels & definitions
JCIA labelling name リン酸(Ca/セリウム): 本品は、炭酸Ca(*)、ピロリン酸カルシウム及びセリウムの焼成物である。
Source: JCIA labelling names (Japan)
Names & identifiers
- CAS No.chemical registry number
- 7790-76-3
- EC No.EU chemical inventory number
- 232-221-5
- DTXSIDUS EPA chemical ID
- DTXSID50872512
- DTXCIDUS EPA compound ID
- DTXCID40820163
- IUPAC
- Dicalcium diphosphate
- Molecular formula
- Ca2O7P2
- Molecular weight
- 254.097 g/mol
Measured properties
- Appearance
- Dry Powder · A fine, white, odourless powder
- Melting point
- 1353 °C
- Solubility
- Insoluble in water. Soluble in dilute hydrochloric and nitric acids · Sol in dil hydrochloric and nitric acids, practically insol in water
- Density
- 3.09
- pH
- Between 5,5 and 7,0 (10 % suspension in water)
- Colour
- white
- Melting/freezing point
- 1353 ℃
- Relative density
- 3.09
- Molecular weight
- 254.10
Values measured on the substance itself. The KOSHA data are a reference for writing and reviewing safety data sheets, not a specification for a commercial raw material.
Source: PubChem · KOSHA safety data sheets (Korea)
What products actually use it for
What the 6 products reported to the US EPA with this ingredient use it for. Products outside cosmetics are included, so the top few rows are its main uses.
- Abrasive3
- Filler1
- Flavouring and nutrient1
- Stabilizing agent1
Source: US EPA CompTox dashboard
Irritation and sensitisation studies
2 skin studies and 4 eye studies are on record.
The study conclusions largely agree (100%). These tests are on the raw material itself; irritation at the amount in a finished product is a different question.
See all 6 studies
- Studies Indicate No Significant Irritation
skin corrosion: in vitro / ex vivo · Screening · EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test) according to OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method) according to - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to OECD Guideline 406 (Skin Sensitisation) - Studies Indicate No Significant Irritation
eye irritation: in vitro / ex vivo · Screening · OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying Ocular Corrosives and Severe Irritants) [before 26 July 2013] according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) 2012 according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to - Ambiguous
eye irritation: in vitro / ex vivo · Screening · OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying Ocular Corrosives and Severe Irritants) [before 26 July 2013] according to EU method B.47 (Bovine corneal opacity and permeability test method for identifying ocular corrosives and severe irritants) according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to
Source: US EPA CompTox dashboard
Related literature
- P028 Crowned dens syndrome: a rare yet important-to-recognise phenotype of calcium pyrophosphate crystal deposition disease · 2025
- Concurrent Post-Zoster Cutaneous Vasculitis and Acute Calcium Pyrophosphate Deposition Disease (CPPD) in an Elderly Patient: A Case Report · 2024
- THU0419 BIOLOGICS IN THE TREATMENT OF CALCIUM PYROPHOSPHATE DEPOSITION DISEASE. A SYSTEMATIC LITERATURE REVIEW · 2020
- Acute calcific tendinitis of gluteus maximus tendon due to tumoral calcium pyrophosphate dihydrate deposition disease · 2017
- Coincidence of monosodium urate monohydrate, calcium pyrophosphate dihydrate, and basic calcium phosphate crystals in the synovial fluid from a single joint · 2016
Linked databases 18
- Australian Industrial Chemicals Inventory (AICIS)
- China inventory of existing ingredients (IECIC)
- EU CosIng ingredient list 2 3
- JCIA labelling names (Japan)
- Korea Cosmetic Association ingredient dictionary
- Korea toxic substances GHS register (NIER)
- KOSHA safety data sheets (Korea)
- MFDS (Korea) cosmetic ingredient register 2
- PubChem 2
- Tlooto literature search 2 3 4 5
- UniChem cross-reference IDs
- US Cosmetic Ingredient Review (CIR) 2
- US EPA CompTox dashboard 2
- US EPA DSSTox chemical database
- US FDA substance registration (GSRS)
- US FDA Unique Ingredient Identifier (UNII)
- Wikidata
- Wikipedia · English · Chinese